Pharmaceutical Marketing, the FDA, and Free Speech.
- Published in:
- Regulation, 2015, v. 38, n. 4, p. 13
- By:
- Publication type:
- Article
Works matching DE "AMARIN Corp. PLC"
Results: 2
1
2
Insurance Coverage and Induced Infringement: A Threat to Hatch-Waxman's Skinny Labeling Pathway?
- Published in:
- University of Chicago Law Review, 2023, v. 90, n. 5, p. 1517
- By:
- Publication type:
- Article